dc.contributor.author
Beck, Lisa A.
dc.contributor.author
Bernstein, Jonathan A.
dc.contributor.author
Maurer, Marcus
dc.date.accessioned
2018-06-08T10:58:34Z
dc.date.available
2017-04-21T11:10:34.791Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/21422
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-24715
dc.description.abstract
Both spontaneous and inducible forms of chronic urticaria pose a significant
economic burden and have an adverse effect on patients’ quality of life. The
international guidelines and US practice parameters for the diagnosis and
management of chronic urticaria both recommend performing a thorough patient
history and physical examination, conducting limited routine laboratory
testing, and taking a stepwise approach to treatment. These documents differ
in several areas, such as the order of diagnostic procedures and the treatment
for patients non-responsive to standard dose H1-antihistamines. Patients with
chronic urticaria who visit a specialist have typically been treated with
second-generation H1-antihistamines – the recommended first-line treatments.
The advantages and disadvantages of each treatment option should be taken into
consideration when selecting therapies beyond H1-antihistamines. Greater
awareness of the international guidelines and US practice parameters will
likely improve the quality of care for patients with chronic urticaria.
en
dc.rights.uri
http://creativecommons.org/licenses/by-nc/4.0/
dc.subject
chronic spontaneous/idiopathic urticaria
dc.subject
physical urticaria
dc.subject
inducible urticaria
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
A Review of International Recommendations for the Diagnosis and Management of
Chronic Urticaria
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Acta Derm Venereol. - 97 (2017), 2, S. 149-158
dcterms.bibliographicCitation.doi
10.2340/00015555-2496
dcterms.bibliographicCitation.url
http://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-2496
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000026848
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000008070
dcterms.accessRights.openaire
open access